Jed Kaminetsky

TL;DR: Tadalafil significantly improved the mean change from baseline in International Prostate Symptom Score at 6 weeks and at 12 weeks and made significant improvements in the Benign Prostatic Hyperplasia Impact Index (significant at12 weeks) vs placebo.

TL;DR: Urinary PCA3 testing in conjunction with prostate specific antigen has the potential to significantly decrease the number of unnecessary prostate biopsies.

TL;DR: Convective water vapor thermal therapy provides rapid and durable improvements in benign prostatic hyperplasia symptoms and preserves erectile and ejaculatory function.

TL;DR: Treatment with tadalafil once daily for lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia showed no negative impact on bladder function as measured by detrusor pressure at maximum urinary flow rate or on any other urodynamic parameter assessed.

TL;DR: Convective water vapor thermal therapy provides sustainable improvements for 12 months to lower urinary tract symptoms and urinary flow while preserving erectile and ejaculatory functions.